Literature DB >> 7547643

The development of the concept of akathisia: a historical overview.

P Sachdev1.   

Abstract

This paper traces the history of 'akathisia' and related syndromes, and examines the important studies that have helped shape our current understanding of the concept. Even though the term has come to be used synonymously with drug-induced akathisia, its origin was in the pre-neuroleptic era, and it is still often used to describe syndromes not related to medication. The literature clearly distinguishes restless legs syndrome (RLS) from akathisia. The complexity of the akathisia syndrome has increasingly become manifest, and a number of sub-types have been described. Recent attempts have been made to operationalize its diagnostic criteria and understand its pathophysiology. Akathisia due to non-neuroleptic drugs, in particular the serotonin-specific reuptake inhibitors (SSRIs), has also received much attention. The development of newer psychopharmacotherapeutic drugs, with different side-effects profiles, has made this focus pertinent and timely.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7547643     DOI: 10.1016/0920-9964(94)00058-g

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  5 in total

1.  Escitalopram-induced severe akathisia: a case report.

Authors:  Yakup Albayrak; Görkem Karakaş Uğurlu; Okan Ekinci; Ali Cayköylü
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Structured relaxation in the treatment of akathisia: case series.

Authors:  Lars K Hansen; Thomas L'allemand; Francine Thiry; David S Baldwin
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-25       Impact factor: 2.570

3.  Delayed-onset akathisia due to amisulpride.

Authors:  Murad Atmaca; Sevda Korkmaz
Journal:  Indian J Pharmacol       Date:  2011-07       Impact factor: 1.200

4.  Venlafaxine induced akathisia: a case report.

Authors:  Sandeep Grover; Vijaya Lakshmi Valaparla
Journal:  Indian J Pharmacol       Date:  2014 Nov-Dec       Impact factor: 1.200

Review 5.  The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis.

Authors:  Jennifer E Thomas; Joshua Caballero; Catherine A Harrington
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.